- The partnership enables Kuehne+Nagel to comply with the highly-regulated Chinese pharma and healthcare sector.
- Jointown and Kuehne+Nagel will collaborate to manage Covid-19 vaccine distribution in a safe and timely manner.
February 24, 2021: After entering into a binding agreement to acquire the Chinese freight forwarder Apex International Corporation, the largest acquisition in the history of Kuehne Nagel, the latter has announced a Chinese collaboration with Jointown, a non-state-owned pharmaceutical distribution company.
The partnership with Jointown now affords access to their fully GxP-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma & healthcare sector.
“We are pleased to be partnering with Jointown. Our cooperation perfectly meets the demands of our global clientele by enabling seamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China,” said Siewloong Wong, president of Kuehne+Nagel Asia Pacific.
Zhang Qingsong, general manager of the logistics business unit of Jointown Pharmaceutical Group, added, “Partnering with Kuehne+Nagel will provide Jointown’s customers access to the international market through their global GxP certified air, sea and overseas contract logistics operations. We will now be able to expand our business in overseas markets at a much faster pace and benefit from the partnership in a sustainable way.”
With Covid-19 vaccines becoming widely approved for use in more countries, Jointown and Kuehne+Nagel will collaborate to manage vaccine distribution in a safe and timely manner, leveraging their respective strengths in vaccine storage and distribution both in China and other parts of the world.
Gianfranco Sgro, member of the management board of Kuehne + Nagel International AG, responsible for Contract Logistics, stated, “Pharma and healthcare is one of the fastest growing sectors in contract logistics. Kuehne+Nagel and Jointown share a common vision of service excellence for patients and customers in China and abroad.”